Bionik Laboratories Corp (BNKL)

Ticker: BNKL Exchange: OTC


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Gaston-Dreyfus Remi Non-Executive Director Large shareholder
Transaction date
Purchase
Price
326.58
Quantity 55,453 +49.2%
Value US$2,238,917
Matine Charles Non-Executive Director
Transaction date
Purchase
Price
384.75
Quantity 24,811 -26.0%
Value US$649,354
Gaston-Dreyfus Remi Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 135,560
Value US$0
Gaston-Dreyfus Remi Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.76
Quantity 106,358 +9.7%
Value US$399,906
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-06-21 2023-06-09 B Purchase Non-Executive Director Large shareholder
55,453 +49.2%
326.58
US$2,238,917
55,453 +49.2% 326.58 US$2,238,917
2023-06-21 2023-06-09 B Purchase Non-Executive Director
24,811 -26.0%
384.75
US$649,354
24,811 -26.0% 384.75 US$649,354
2023-06-21 2023-06-09 B Purchase Non-Executive Director
80,665 -44.8%
46.92
US$1,394,433
80,665 -44.8% 46.92 US$1,394,433
2021-12-13 2021-03-26 B Purchase Non-Executive Director Large shareholder
135,560
0.00
US$0
135,560 0.00 US$0
2021-04-01 2021-03-26 B Purchase

Chairman

Executive Director
95,149
0.00
US$0
95,149 0.00 US$0
2019-08-28 2019-08-26 B Purchase Gaston-Dreyfus Remi Non-Executive Director Large shareholder
106,358 +9.7%
3.76
US$399,906
106,358 +9.7% 3.76 US$399,906